As regards to immunotherapy-based combinations, in BC it was observed a synergistic effect between γδ and αβ CD8+ T cells occurring via the inhibition of farnesyl pyrophosphate synthase (FPPS), which allows it to overcome the resistance of CSC-like cells to γδ T cells. The gene discussed is CD8A; the disease is breast cancer.